These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15231693)

  • 1. Muscle-specific overexpression of CD36 reverses the insulin resistance and diabetes of MKR mice.
    Héron-Milhavet L; Haluzik M; Yakar S; Gavrilova O; Pack S; Jou WC; Ibrahimi A; Kim H; Hunt D; Yau D; Asghar Z; Joseph J; Wheeler MB; Abumrad NA; LeRoith D
    Endocrinology; 2004 Oct; 145(10):4667-76. PubMed ID: 15231693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor-alpha agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and improves glucose homeostasis.
    Kim H; Haluzik M; Asghar Z; Yau D; Joseph JW; Fernandez AM; Reitman ML; Yakar S; Stannard B; Heron-Milhavet L; Wheeler MB; LeRoith D
    Diabetes; 2003 Jul; 52(7):1770-8. PubMed ID: 12829645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phloridzin improves hyperglycemia but not hepatic insulin resistance in a transgenic mouse model of type 2 diabetes.
    Zhao H; Yakar S; Gavrilova O; Sun H; Zhang Y; Kim H; Setser J; Jou W; LeRoith D
    Diabetes; 2004 Nov; 53(11):2901-9. PubMed ID: 15504971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human insulin-like growth factor-I treatment inhibits gluconeogenesis in a transgenic mouse model of type 2 diabetes mellitus.
    Pennisi P; Gavrilova O; Setser-Portas J; Jou W; Santopietro S; Clemmons D; Yakar S; LeRoith D
    Endocrinology; 2006 Jun; 147(6):2619-30. PubMed ID: 16513827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac and skeletal muscle fatty acid transport and transporters and triacylglycerol and fatty acid oxidation in lean and Zucker diabetic fatty rats.
    Bonen A; Holloway GP; Tandon NN; Han XX; McFarlan J; Glatz JF; Luiken JJ
    Am J Physiol Regul Integr Comp Physiol; 2009 Oct; 297(4):R1202-12. PubMed ID: 19675275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes.
    Fernández AM; Kim JK; Yakar S; Dupont J; Hernandez-Sanchez C; Castle AL; Filmore J; Shulman GI; Le Roith D
    Genes Dev; 2001 Aug; 15(15):1926-34. PubMed ID: 11485987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD36 deficiency increases insulin sensitivity in muscle, but induces insulin resistance in the liver in mice.
    Goudriaan JR; Dahlmans VE; Teusink B; Ouwens DM; Febbraio M; Maassen JA; Romijn JA; Havekes LM; Voshol PJ
    J Lipid Res; 2003 Dec; 44(12):2270-7. PubMed ID: 12923231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MKR mice are resistant to the metabolic actions of both insulin and adiponectin: discordance between insulin resistance and adiponectin responsiveness.
    Kim CH; Pennisi P; Zhao H; Yakar S; Kaufman JB; Iganaki K; Shiloach J; Scherer PE; Quon MJ; LeRoith D
    Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E298-305. PubMed ID: 16507604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leptin improves insulin resistance and hyperglycemia in a mouse model of type 2 diabetes.
    Toyoshima Y; Gavrilova O; Yakar S; Jou W; Pack S; Asghar Z; Wheeler MB; LeRoith D
    Endocrinology; 2005 Sep; 146(9):4024-35. PubMed ID: 15947005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MKR mice have increased dynamic glucose disposal despite metabolic inflexibility, and hepatic and peripheral insulin insensitivity.
    Vaitheesvaran B; LeRoith D; Kurland IJ
    Diabetologia; 2010 Oct; 53(10):2224-32. PubMed ID: 20577711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic Overexpression of CD36 Improves Glycogen Homeostasis and Attenuates High-Fat Diet-Induced Hepatic Steatosis and Insulin Resistance.
    Garbacz WG; Lu P; Miller TM; Poloyac SM; Eyre NS; Mayrhofer G; Xu M; Ren S; Xie W
    Mol Cell Biol; 2016 Nov; 36(21):2715-2727. PubMed ID: 27528620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.
    Hong EG; Jung DY; Ko HJ; Zhang Z; Ma Z; Jun JY; Kim JH; Sumner AD; Vary TC; Gardner TW; Bronson SK; Kim JK
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1687-96. PubMed ID: 17911348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance causes increased beta-cell mass but defective glucose-stimulated insulin secretion in a murine model of type 2 diabetes.
    Asghar Z; Yau D; Chan F; Leroith D; Chan CB; Wheeler MB
    Diabetologia; 2006 Jan; 49(1):90-9. PubMed ID: 16362284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A null mutation in skeletal muscle FAT/CD36 reveals its essential role in insulin- and AICAR-stimulated fatty acid metabolism.
    Bonen A; Han XX; Habets DD; Febbraio M; Glatz JF; Luiken JJ
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1740-9. PubMed ID: 17264223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E deficiency abrogates insulin resistance in a mouse model of type 2 diabetes mellitus.
    Kawashima Y; Chen J; Sun H; Lann D; Hajjar RJ; Yakar S; Leroith D
    Diabetologia; 2009 Jul; 52(7):1434-41. PubMed ID: 19436992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle-specific overexpression of FAT/CD36 enhances fatty acid oxidation by contracting muscle, reduces plasma triglycerides and fatty acids, and increases plasma glucose and insulin.
    Ibrahimi A; Bonen A; Blinn WD; Hajri T; Li X; Zhong K; Cameron R; Abumrad NA
    J Biol Chem; 1999 Sep; 274(38):26761-6. PubMed ID: 10480880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo, fatty acid translocase (CD36) critically regulates skeletal muscle fuel selection, exercise performance, and training-induced adaptation of fatty acid oxidation.
    McFarlan JT; Yoshida Y; Jain SS; Han XX; Snook LA; Lally J; Smith BK; Glatz JF; Luiken JJ; Sayer RA; Tupling AR; Chabowski A; Holloway GP; Bonen A
    J Biol Chem; 2012 Jul; 287(28):23502-16. PubMed ID: 22584574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiazolidinediones improve insulin sensitivity in adipose tissue and reduce the hyperlipidaemia without affecting the hyperglycaemia in a transgenic model of type 2 diabetes.
    Kim H; Haluzik M; Gavrilova O; Yakar S; Portas J; Sun H; Pajvani UB; Scherer PE; LeRoith D
    Diabetologia; 2004 Dec; 47(12):2215-25. PubMed ID: 15662559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipose and muscle tissue profile of CD36 transcripts in obese subjects highlights the role of CD36 in fatty acid homeostasis and insulin resistance.
    Pietka TA; Schappe T; Conte C; Fabbrini E; Patterson BW; Klein S; Abumrad NA; Love-Gregory L
    Diabetes Care; 2014 Jul; 37(7):1990-7. PubMed ID: 24784828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic mice overexpressing insulin-like growth factor-II in beta cells develop type 2 diabetes.
    Devedjian JC; George M; Casellas A; Pujol A; Visa J; Pelegrín M; Gros L; Bosch F
    J Clin Invest; 2000 Mar; 105(6):731-40. PubMed ID: 10727441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.